Literature DB >> 21494227

Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.

Miriam Promintzer-Schifferl1, Gerhard Prager, Christian Anderwald, Martina Mandl, Harald Esterbauer, Soheila Shakeri-Leidenmühler, Giovanni Pacini, Marietta Stadler, Martin G Bischof, Bernhard Ludvik, Aanton Luger, Michael Krebs.   

Abstract

Roux-en-Y-Gastric-Bypass (RYGB) reduces overall and diabetes-specific mortality by 40% and over 90%. This study aims to gain insight into the underlying mechanisms of this effect. We evaluated time-courses of glucose, insulin, C-peptide, and the incretin glucagon like peptide-1 (GLP-1) following an oral glucose load. Insulin-sensitivity was measured by a hyperinsulinemic-isoglycemic-clamp-test; glucose-turnover was determined using D-[6,6-(2)H(2)] glucose. Examinations were performed in six nondiabetic patients with excess weight before (PRE: BMI: 49.3 ± 3.2 kg/m(2)) and 7 months after RYGB (POST: BMI: 36.7 ± 2.9 kg/m(2)), in a lean (CON: BMI: 22.6 ± 0.6 kg/m(2)) and an obese control group (CONob) without history of gastrointestinal surgery (BMI: 34.7 ± 1.2 kg/m(2)). RYGB reduced fasting plasma concentrations of insulin and C-peptide (P < 0.01, respectively) whereas fasting glucose concentrations remained unchanged. After RYGB increase of C-peptide concentration following glucose ingestion was significantly higher compared to all other groups (dynamic-area under the curve (Dyn-AUC): 0-90 min: POST: 984 ± 115 ng·min/ml, PRE: 590 ± 67 ng·min/ml, CONob: 440 ± 44 ng·min/ml, CON: 279 ± 22 ng·min/ml, P < 0.01 respectively). Early postprandial increase of glucose concentration was however not affected. GLP-1 concentrations following glucose ingestion were sixfold higher after RYBG than before (P = 0.01). Insulin-stimulated glucose uptake tended to increase postoperatively (M-value: PRE: 1.8 ± 0.5, POST: 3.0 ± 0.3, not significant (n.s.)). Endogenous glucose production (EGP) was unaffected by RYGB. Hepatic insulin resistance index improved after RYGB and was then comparable to both control groups (PRE: 29.2 ± 4.3, POST: 12.6 ± 1.1, P < 0.01). RYGB results in hyper-secretion of insulin and C-peptide, whereas improvements of insulin resistance are minor and seem to occur rather in the liver and the adipose tissue than in the skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494227     DOI: 10.1038/oby.2011.92

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  15 in total

Review 1.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Authors:  C Dirksen; N B Jørgensen; K N Bojsen-Møller; S H Jacobsen; D L Hansen; D Worm; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

2.  Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery.

Authors:  Jonathan Foo; Jeremy Krebs; Mark Thomas Hayes; Damon Bell; Donia Macartney-Coxson; Tony Croft; Richard Strawson Stubbs
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

3.  Metabolic consequences of the incorporation of a Roux limb in an omega loop (mini) gastric bypass: evaluation by a glucose tolerance test at mid-term follow-up.

Authors:  Jacques M Himpens; Ramon Vilallonga; Guy-Bernard Cadière; Guido Leman
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

Review 4.  Gastrointestinal changes after bariatric surgery.

Authors:  I Quercia; R Dutia; D P Kotler; S Belsley; B Laferrère
Journal:  Diabetes Metab       Date:  2013-12-17       Impact factor: 6.041

Review 5.  A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.

Authors:  Pichamol Jirapinyo; David X Jin; Taha Qazi; Nitin Mishra; Christopher C Thompson
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

Review 6.  The role of bariatric surgery in the treatment of diabetes.

Authors:  Ji Chung Tham; Noah Howes; Carel W le Roux
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 7.  Bariatric and metabolic surgery: a shift in eligibility and success criteria.

Authors:  Gema Frühbeck
Journal:  Nat Rev Endocrinol       Date:  2015-06-09       Impact factor: 43.330

8.  Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.

Authors:  Juliet F Zechner; Uyenlinh L Mirshahi; Santhosh Satapati; Eric D Berglund; Jari Rossi; Michael M Scott; Christopher D Still; Glenn S Gerhard; Shawn C Burgess; Tooraj Mirshahi; Vincent Aguirre
Journal:  Gastroenterology       Date:  2012-11-15       Impact factor: 22.682

Review 9.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

10.  Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: A prospective study in Mashhad, Iran.

Authors:  Sahar Fallahi-Shahabad; Mohsen Mazidi; Alireza Tavasoli; Peyman Rezaie; Fatemeh Rohani; Simindokht Habibzadeh; Emadodin Darchini-Maragheh; Zohreh Sadat Sang Sefidi; Mohammad Safarian; Majid Ghayour Mobarhan; Mohammad Taghi Rajabi; Abdolreza Norouzy; Seyed Mohammad Reza Parizadeh; Saeid Akhlaghi; Shima Tavalaie; Fatemeh Firouzi; Mohsen Nematy
Journal:  Indian J Gastroenterol       Date:  2016-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.